ENANTA PHARMACEUTICALS INC Quarterly Return On Equity in % from Q4 2013 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Enanta Pharmaceuticals Inc quarterly/annual Return On Equity history and growth rate from Q4 2013 to Q2 2024.
  • Enanta Pharmaceuticals Inc Return On Equity for the quarter ending June 30, 2024 was -63.8 %, a 36.3% decline year-over-year.
  • Enanta Pharmaceuticals Inc annual Return On Equity for 2023 was -52.2 %, a 50.4% decline from 2022.
  • Enanta Pharmaceuticals Inc annual Return On Equity for 2022 was -34.7 %, a 87.4% decline from 2021.
  • Enanta Pharmaceuticals Inc annual Return On Equity for 2021 was -18.5 %, a 144% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -63.8 -17 -36.3% Apr 1, 2024 Jun 30, 2024
Q1 2024 -64.9 -24.3 -59.9% Jan 1, 2024 Mar 31, 2024
Q4 2023 -60.4 -23.8 -65% Oct 1, 2023 Dec 31, 2023
Q3 2023 -52.2 -17.5 -50.4% Jul 1, 2023 Sep 30, 2023
Q2 2023 -46.8 -14.4 -44.3% Apr 1, 2023 Jun 30, 2023
Q1 2023 -40.6 -11.8 -40.9% Jan 1, 2023 Mar 31, 2023
Q4 2022 -36.6 -12 -48.6% Oct 1, 2022 Dec 31, 2022
Q3 2022 -34.7 -16.2 -87.4% Jul 1, 2022 Sep 30, 2022
Q2 2022 -32.4 -13.4 -70.5% Apr 1, 2022 Jun 30, 2022
Q1 2022 -28.8 -12.6 -77.5% Jan 1, 2022 Mar 31, 2022
Q4 2021 -24.6 -12.3 -99.1% Oct 1, 2021 Dec 31, 2021
Q3 2021 -18.5 -10.9 -144% Jul 1, 2021 Sep 30, 2021
Q2 2021 -19 -19.5 -3944% Apr 1, 2021 Jun 30, 2021
Q1 2021 -16.2 -21.3 -422% Jan 1, 2021 Mar 31, 2021
Q4 2020 -12.4 -19.8 -267% Oct 1, 2020 Dec 31, 2020
Q3 2020 -7.6 -18.1 -173% Jul 1, 2020 Sep 30, 2020
Q2 2020 0.49 -14.7 -96.8% Apr 1, 2020 Jun 30, 2020
Q1 2020 5.04 -14.2 -73.9% Jan 1, 2020 Mar 31, 2020
Q4 2019 7.39 -15.4 -67.6% Oct 1, 2019 Dec 31, 2019
Q3 2019 10.5 -10 -48.9% Jul 1, 2019 Sep 30, 2019
Q2 2019 15.2 -9.52 -38.6% Apr 1, 2019 Jun 30, 2019
Q1 2019 19.3 +2 +11.6% Jan 1, 2019 Mar 31, 2019
Q4 2018 22.8 +10.8 +89.8% Oct 1, 2018 Dec 31, 2018
Q3 2018 20.5 +14 +217% Jul 1, 2018 Sep 30, 2018
Q2 2018 24.7 +32.4 Apr 1, 2018 Jun 30, 2018
Q1 2018 17.3 +22.2 Jan 1, 2018 Mar 31, 2018
Q4 2017 12 +15.5 Oct 1, 2017 Dec 31, 2017
Q3 2017 6.46 -1.64 -20.2% Jul 1, 2017 Sep 30, 2017
Q2 2017 -7.74 -19 -168% Apr 1, 2017 Jun 30, 2017
Q1 2017 -4.94 -18.1 -137% Jan 1, 2017 Mar 31, 2017
Q4 2016 -3.54 -30.1 -113% Oct 1, 2016 Dec 31, 2016
Q3 2016 8.1 -27.7 -77.4% Jul 1, 2016 Sep 30, 2016
Q2 2016 11.3 -23 -67% Apr 1, 2016 Jun 30, 2016
Q1 2016 13.2 -51.2 -79.5% Jan 1, 2016 Mar 31, 2016
Q4 2015 26.5 -28.3 -51.6% Oct 1, 2015 Dec 31, 2015
Q3 2015 35.8 +8.74 +32.3% Jul 1, 2015 Sep 30, 2015
Q2 2015 34.3 +4.52 +15.2% Apr 1, 2015 Jun 30, 2015
Q1 2015 64.4 +82.1 Jan 1, 2015 Mar 31, 2015
Q4 2014 54.8 +70.6 Oct 1, 2014 Dec 31, 2014
Q3 2014 27.1 Jul 1, 2014 Sep 30, 2014
Q2 2014 29.8 Apr 1, 2014 Jun 30, 2014
Q1 2014 -17.7 Jan 1, 2014 Mar 31, 2014
Q4 2013 -15.8 Oct 1, 2013 Dec 31, 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.